BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30314924)

  • 21. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
    Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
    Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Asghari S; Asghari-Jafarabadi M; Somi MH; Ghavami SM; Rafraf M
    J Am Coll Nutr; 2018; 37(3):223-233. PubMed ID: 29313746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.
    Eslamparast T; Tandon P; Raman M
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction.
    Browning JD; Baker JA; Rogers T; Davis J; Satapati S; Burgess SC
    Am J Clin Nutr; 2011 May; 93(5):1048-52. PubMed ID: 21367948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of efficacy of low-carbohydrate and low-fat diet education programs in non-alcoholic fatty liver disease: A randomized controlled study.
    Jang EC; Jun DW; Lee SM; Cho YK; Ahn SB
    Hepatol Res; 2018 Feb; 48(3):E22-E29. PubMed ID: 28593701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Errors in meta-analysis should be corrected in "Critical appraisal for low-carbohydrate diet in non-alcoholic fatty liver disease: Review and meta-analyses".
    Henschel B; Dickinson SL; Allison DB
    Clin Nutr; 2021 Jul; 40(7):4535-4536. PubMed ID: 34229256
    [No Abstract]   [Full Text] [Related]  

  • 28. The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
    Parker A; Kim Y
    Metab Syndr Relat Disord; 2019 Oct; 17(8):389-396. PubMed ID: 31305201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity.
    Cunha GM; Guzman G; Correa De Mello LL; Trein B; Spina L; Bussade I; Marques Prata J; Sajoux I; Countinho W
    Front Endocrinol (Lausanne); 2020; 11():607. PubMed ID: 33042004
    [No Abstract]   [Full Text] [Related]  

  • 30. [The role of diet in non-alcoholic fatty liver disease].
    Jun DW
    Korean J Gastroenterol; 2013 May; 61(5):243-51. PubMed ID: 23756665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease.
    Chen J; Huang Y; Xie H; Bai H; Lin G; Dong Y; Shi D; Wang J; Zhang Q; Zhang Y; Sun J
    Asia Pac J Clin Nutr; 2020; 29(3):483-490. PubMed ID: 32990607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
    BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial.
    Properzi C; O'Sullivan TA; Sherriff JL; Ching HL; Jeffrey GP; Buckley RF; Tibballs J; MacQuillan GC; Garas G; Adams LA
    Hepatology; 2018 Nov; 68(5):1741-1754. PubMed ID: 29729189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
    Naudin CR; Maner-Smith K; Owens JA; Wynn GM; Robinson BS; Matthews JD; Reedy AR; Luo L; Wolfarth AA; Darby TM; Ortlund EA; Jones RM
    Gastroenterology; 2020 Aug; 159(2):639-651.e5. PubMed ID: 32169430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction.
    Risi R; Tozzi R; Watanabe M
    Curr Opin Clin Nutr Metab Care; 2021 Jul; 24(4):349-353. PubMed ID: 33871418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responses of the Serum Lipid Profile to Exercise and Diet Interventions in Nonalcoholic Fatty Liver Disease.
    Qi Z; LE S; Cheng R; DU X; Zhao C; Zhang Z; Zhang X; Feng L; Schumann M; Mao L; Cheng S
    Med Sci Sports Exerc; 2024 Jun; 56(6):1036-1045. PubMed ID: 38247038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic review.
    Varkaneh HK; Poursoleiman F; Al Masri MK; Alras KA; Shayah Y; Masmoum MD; Alangari FA; Alras AA; Rinaldi G; Day AS; Hekmatdoost A; Abu-Zaid A; Kutbi E
    Front Nutr; 2022; 9():987921. PubMed ID: 36051903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.